New Homocamptothecin Boosts Pancreatic Cancer Radiotherapy
In a groundbreaking study published in BMC Cancer, researchers have unveiled a promising new radiosensitizing agent, TOP-0618, a derivative of ...
In a groundbreaking study published in BMC Cancer, researchers have unveiled a promising new radiosensitizing agent, TOP-0618, a derivative of ...
In a groundbreaking advance that promises to revolutionize cancer treatment and pharmaceutical manufacturing, researchers from the University of Copenhagen have ...
In a remarkable convergence of clinical innovation and translational research, the Sylvester Comprehensive Cancer Center is poised to make a ...
In a groundbreaking advance for the treatment of head and neck cancers, researchers have unveiled promising results from a phase ...
In a groundbreaking stride towards redefining treatment paradigms for muscle-invasive bladder cancer (MIBC), a multicenter phase II clinical trial is ...
A groundbreaking clinical trial led by researchers at Cambridge University has unveiled a treatment regimen that markedly improves survival outcomes ...
A groundbreaking new compound named SHP1705 is generating excitement in the fight against glioblastoma, the most aggressive and lethal brain ...
In the evolving battleground of oncology, few molecular targets have captured as much attention and complexity as the MYC protein. ...
A groundbreaking study conducted by researchers at Osaka Metropolitan University has unveiled promising therapeutic potential for plasma-activated medium (PAM) in ...
In a groundbreaking advancement for urothelial carcinoma (UC) treatment, recent findings have shed light on the therapeutic potential of RC48-ADC, ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine